Paper
Receptors for the age of anxiety: pharmacology of the benzodiazepines.
Published Jan 18, 1980 · J. Tallman, S. Paul, P. Skolnick
Science
794
Citations
8
Influential Citations
Abstract
Investigation of the actions of the benzodiazepines has provided insights into the neurochemical mechanisms underlying anxiety, seizures, muscle relaxation, and sedation. Behavioral, electrophysical, pharmacological, and biochemical evidence indicates that the benzodiazepines exert their therapeutic effects by interacting with a high-affinity binding site (receptor) in the brain. The benzodiazepine receptor interacts with a receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter, and enhances its inhibitory effects. The benzodiazepine receptor may also interact with endogenous substances and several naturally occurring compounds, including the purines and nicotinamide, are candidates for this role. Both the purines and nicotinamide possess some benzodiazepine-like properties in vivo, although further work will be required to confirm their possible roles as endogenous benzodiazepines.
Benzodiazepines effectively treat anxiety, seizures, muscle relaxation, and sedation by interacting with a high-affinity binding site in the brain, which may also interact with endogenous substances like purines and nicotinamide.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...